REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07393282 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-03-25 → 2026-05-21 3. completion date: 2033-07-22 → 2033-07-27 4. primary completion date: 2033-07-22 → 2033-07-27
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical